Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Survival After Introduction Of HAART In People With Known Duration Of HIV-1 Infection
The Cascade Collaboration
Published 2000 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
We compared survival from HIV-1 seroconversion before and during the periods of highly-active antiretroviral therapy (HAART). Survival expectations were substantially better for HIV-1-infected individuals in 1997-98 (HAART period) compared with those in 1986-96 (pre-HAART period). Estimated survival 10 years from seroconversion was also substantially better in the later period.
This paper is referenced by
The changing clinical epidemiology of AIDS in the highly active antiretroviral therapy era
C. Sabin (2002)
SAARC Journal of Tuberculosis, Lung Diseases and HIV/AIDS
V. S. Salhotra (2009)
Mid-term outcomes in HIV-positive patients after primary total hip or knee arthroplasty.
C. Lin (2014)
Economic and epidemiological impact of early antiretroviral therapy initiation in India
Manoj V Maddali (2015)
Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category
S. Pérez-Hoyos (2003)
Progression of HIV infection and mortality by hepatitis C infection in patients with haemophilia over 20 years
M. Quintana (2003)
ncreased syphilis trend among patients in an AIDS information and prevention enter
sabel Hurtadoa (2018)
HIV testing and the role of individual- and structural-level barriers and facilitators
L. Bond (2005)
The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals.
R. Janssen (2001)
Dramatic improvement in survival among adult Brazilian AIDS patients
J. Marins (2003)
La santé mentale des femmes séropositives en France à l'ère des thérapies antirétrovirales : quelles différences avec les hommes ? Quels enjeux ?
Marie Préau (2008)
The Impact of Illicit Drug Use on Adherence to Antiretroviral Therapy among HIV-Infected US Women
Y. Zhang (2015)
Malignancy‐related causes of death in human immunodeficiency virus–infected patients in the era of highly active antiretroviral therapy
F. Bonnet (2004)
Impact of HIV/AIDS on care and outcomes of severe sepsis
J. Mrus (2005)
Older age and plasma viral load in HIV-1 infection
K. Goodkin (2004)
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?
A. Mocroft (2005)
CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era
S. Lodi (2010)
Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users.
W. Tun (2004)
Oral contraception and unprotected sex with occasional partners of women HIV-infected through injection drug use
M. P. Carrieri (2006)
Präoperative Risikoabschätzung und perioperatives Management HIV-infizierter Patienten
K. Becker (2001)
Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine.
N. Merchante (2010)
The Effect of HAART on HIV RNA Trajectory Among Treatment-naïve Men and Women: A Segmental Bernoulli/Lognormal Random Effects Model With Left Censoring
Haitao Chu (2010)
Antiretroviral therapy and declining AIDS mortality in New York City
T. Wong (2006)
Principal components analysis of drug expenditure and utilisation trends for major therapeutic classes in US Medicaid programmes
J. Guo (2008)
PREVALÊNCIA DE DOENÇA RENAL CRÔNICA EM PACIENTES HIV-POSITIVO ACOMPANHADOS NO HC-UFPR
Eduardo Henrique Bonotto (2017)
Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohorts.
P. Tarwater (2001)
[Mortality and morbidity in HIV-infected patients undergoing coronary artery bypass surgery: a case control study].
M. J. Jiménez-Expósito (2006)
Oxidative Imbalance in HIV-1 Infected Patients Treated with Antiretroviral Therapy
A. Mandas (2009)
The Benefits of Exercise Training for Quality of Life in HIV/AIDS in the Post-HAART Era
J. Ciccolo (2004)
Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.
C. Lewden (2005)
No Association of Abacavir Use With Myocardial Infarction: Findings of an FDA Meta-Analysis
X. Ding (2012)
Épidémiologie des atteintes coronaires au cours de l’infection par le VIH
Murielle Mary-Krause (2005)See more